MCNAB JAMES R 4
4 · TITAN PHARMACEUTICALS INC · Filed Jan 28, 2022
Insider Transaction Report
Form 4
MCNAB JAMES R
Director
Transactions
- Other
Common Stock
2022-01-28+51,021→ 51,021 total(indirect: By JT Pharma)
Holdings
- 1,669
Common Stock
Footnotes (1)
- [F1]Represents $50,000 of shares issued to JT Pharmaceuticals, Inc. ("JT") as a milestone payment under the October 2020 asset purchase agreement. Mr. McNab is a principal of JT and has voting and dispositive control of such shares.